Exploring Key Insights of the Arthritic Therapeutic Market: Growth Prospects, Emerging Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Rapidly is the Arthritic Therapeutic Market Expected to Expand Between 2025 and 2034 Based on Current Trends?
In recent times, the arthritic therapeutic market has shown robust growth. This sector is projected to expand from a value of $68.1 billion in 2024 to $72.44 billion in 2025, marking a compound annual growth rate (CAGR) of 6.4%. Factors contributing to such historical growth include a rise in diagnosed patients, enhanced education regarding symptoms, a higher incidence of obesity, advanced diagnostic competencies, and better treatment results.
Over the coming years, the size of the arthritic therapeutic market is predicted to increase significantly, reaching $91.72 billion in 2029 with a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this growth include enhancements in healthcare infrastructure, government-led initiatives, supportive regulatory environments, an emphasis on personalized medicine, and a move toward healthcare practices that place the patient at the center. During the forecasted period, the market is expected to be dominated by specific trends such as a focus on biosimilars, a shift toward biologics, increased accessibility of biosimilars, a preference for the parenteral route, and the expansion of online pharmacies.
What Strategic Factors Are Influencing the Accelerated Growth of the Arthritic Therapeutic Market?
The rising occurrence of arthritis is anticipated to boost the expansion of the arthritic therapeutic market in the future. Arthritis, a collective term for over 100 conditions primarily marked by joint pain and inflammation, is on the rise due to factors such as an aging populace, higher rates of obesity, and lifestyle aspects leading to joint stress and inflammation. Arthritis therapies help alleviate symptoms, reduce inflammation, and enhance joint function, thus significantly improving the life quality for those suffering. As per a report in June 2024 by the Australian Institute of Health and Welfare, a government organization based in Australia, approximately 514,000 individuals (equating to 2.0% of the population) were diagnosed with rheumatoid arthritis in 2022. Rheumatoid arthritis accounted for 2.0% of the overall disease-related burden and contributed to 16% of the total load of all musculoskeletal disorders in 2023. As such, the escalating occurrence of arthritis is a significant factor in the growth of the arthritic therapeutic market.
Request Your Free Arthritic Therapeutic Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=19297&type=smp
Which Key Players Are Shaping the Future of the Arthritic Therapeutic Market?
Major companies operating in the arthritic therapeutic market are Pfizer Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Pharma AB, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Incyte Corporation, Celltrion Inc., Mallinckrodt Pharmaceuticals, Genentech Inc., Anika Therapeutics Inc., Medac GmbH
How Are the Latest Trends Influencing the Growth of the Arthritic Therapeutic Market?
Leading businesses within the therapeutic arthritis market are channeling their efforts towards creating novel solutions like biosimilar monoclonal antibody-based therapies. This approach is anticipated to boost the efficacy of treatments and drive down costs. Offering a replica of the efficacy of original monoclonal antibodies, biosimilar monoclonal antibody-based therapies supply similar therapeutic advantages at possible lower prices. Bio-Thera Solutions Ltd., a biopharmaceutical enterprise based in China, launched an intravenous biosimilar monoclonal antibody formulation called TOFIDENCE in May 2024. It mimics the reference drug ACTEMRA and is approved for use in treating moderate to severe rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and systemic juvenile idiopathic arthritis.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/arthritic-therapeutic-global-market-report
What Major Market Segments Define the Scope and Growth of the Arthritic Therapeutic Market?
The arthritic therapeuticmarket covered in this report is segmented –
1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Type: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab
2) By Interleukin Inhibitors: Interleukin-6 (IL-6) Inhibitors, Interleukin-1 (IL-1) Inhibitors, Interleukin-17 (IL-17) Inhibitors, Interleukin-23 (IL-23) Inhibitors
3) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Meloxicam
4) By Corticosteroids: Prednisone, Methylprednisolone, Hydrocortisone, Dexamethasone
5) By Xanthine Oxidase Inhibitors: Allopurinol, Febuxostat
6) By Other Drug Classes: Disease-Modifying Antirheumatic Drugs (DMARDs), Janus Kinase (JAK) Inhibitors, Biologic DMARDs, Topical Analgesics, Opioid Pain Medications
What Regions Are At the Forefront of Arthritic Therapeutic Market Expansion?
North America was the largest region in the arthritic therapeutic market in 2024. The regions covered in the arthritic therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Core Features That Define the Arthritic Therapeutic Market?
Arthritic therapeutics refer to treatments designed to alleviate symptoms and improve quality of life for individuals with arthritis. This includes medications, physical therapy, and other interventions aimed at reducing pain, inflammation, and joint damage. These therapies can help manage various forms of arthritis, such as osteoarthritis and rheumatoid arthritis.
Browse Through More Similar Reports By The Business Research Company:
Glycomic Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/glycomic-therapeutics-global-market-report
Gout Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report
Gastroesophageal Reflux Disease Therapeutics Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
